Collectively, our data suggest that one mechanism by which obesity and weight gain promote breast cancer progression is through estrogen-independent ER activation and cancer cell metabolic reprogramming, partly driven by FGF/FGFR. This evidence concerns the gene ESR1 and obesity due to melanocortin 4 receptor deficiency.